(Q87259669)

English

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label tr

scientific article published on 13 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Daisuke Aoki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

11

object named as

Toru Sugiyama

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Noriyuki Katsumata

1

object named as

Noriyuki Katsumata

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Makoto Yasuda

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Seiji Isonishi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Fumiaki Takahashi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Hirofumi Michimae

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Eizo Kimura

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Toshiko Jobo

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Shoji Kodama

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Fumitoshi Terauchi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Kazunori Ochiai

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Japanese Gynecologic Oncology Group

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

13 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1020-1026

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

First-line therapy in ovarian cancer trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Letter: Creatinine clearance: bedside estimate.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Incorporation of bevacizumab in the primary treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Revised equations for estimated GFR from serum creatinine in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970363-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(13)70363-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23948349%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q87259669&oldid=1822356921"